Evolución alejada en portadoras asintomáticos HBsAg(PA-HBsAg) en un área de baja prevalencia de hepatocarcinoma
Acta gastroenterol. latinoam
;
19(1): 21-30, jan.-mar. 1989. tab
Artículo
en Español
| LILACS
| ID: lil-76189
RESUMO
Data provided by 51 voluntaru blood donnors identified as asymptomatic HBsAg carriers five to ten years (x = 7.5 years) before their inclusion in the study are analysed towards their long-term evolution. HBsAg clearance was estimated 2.5% yearly and 83.9% of those remaining positive showed the classical non-replicative serological pattern,; another 12.9% were negative for both HBeAg - Anti HBe (serovonversion window?), one of them presenting raised ASATALAT levels and enhanced histological activity (lobular chronic hepatitis). Neither alpha-fetoprotein seric levels (RIA) nor liver ultrasonography demonstrated hepato cellular carcinoma suspicion signs in 35 HBsAg positive cases to this methods; ASAT-ALAT levels raised over two fold the normal superior limit ion only 11.4%, and neither agressive chronic liver disease nor hepatocyte dissplasia was showed in 17 biopsed cases (70.6% normal; 23.6% chronic reactive or chronic persistent hepatitis; 5.8% chronic liobular hepatitis). One out of five patients biopsed with a seven years interval showed histologic worsening
Buscar en Google
Índice:
LILACS (Américas)
Asunto principal:
Virus de la Hepatitis B
/
Carcinoma Hepatocelular
/
Hepatitis B
/
Antígenos de Superficie de la Hepatitis B
/
Neoplasias Hepáticas
Tipo de estudio:
Estudio de prevalencia
/
Factores de riesgo
/
Estudio de tamizaje
Límite:
Humanos
Idioma:
Español
Revista:
Acta gastroenterol. latinoam
Asunto de la revista:
Gastroenterologia
Año:
1989
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS